Giants of Cancer Care® Program Inductees

Melanoma

Steven A. Rosenberg, MD, PhD

National Cancer Institute

Pioneered the use of adoptive immunotherapy.
Chief of Surgery at the National Cancer Institute.
Credited with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive cell transfer.
Has shown that expanding immune cells (known as tumor infiltrating lymphocytes) in the lab can be used to treat patients with melanoma.

Home

)

SUPPORTED BY